DNAprint Genomics (DNAG)

[dgplexus]

Frogdreaming,

Allow me to point out: BioServe, DNA Direct, Beckman Coulter... those recent deals alone refute what you said below. Clearly, multiple corporate entities, not "no one," are interested in what DNAG has to offer.

You said, "As far as I'm concerned there is absolutely no substance to the 'option' premise. It is a red herring to cover the fact that no one is remotely interested in anything DNAG has to offer."

Orchid option or not, I understand that time scale in biotech can stretch many investors' patience, especially when slowed by financing concerns. DNAPrint appears to be moving ahead in its own time, significant movement now. Extraordinary explanations are not required (though bashers have obviously played a role in driving and keeping the stock price down. Concocting conspiracy theories and behaving as wet blankets do not help shareholders. If any basher was a shareholder, he/she would be harming his/her own investment, as well. If any basher is not a shareholder today, continuing to bash is uncalled for, and harmful to others, and to DNAPrint Genomics, in my opinion.) Bashers aside, some very positive things have developed recently with DNAPrint... I think people will stop listening to the bashers, especially as things continue to improve. But by that time, people wishing to buy in, will have to do so at a higher price. People willing to take a greater degree of risk by investing earlier, including myself, stand to have better returns.